Resiniferatoxin Completed Phase 1 Trials for Intractable Cancer Pain Treatment
Indications | Status | Purpose | Phase |
---|---|---|---|
Completed | Treatment | 1 |
clinicaltrials.gov Identifier | Title | Drugs |
---|---|---|
NCT03226574 | Study to Evaluate Safety and MTD of Epidural Resiniferatoxin Injection for Treatment of Intractable Cancer Pain |